Research Article

Serum Protein KNG1, APOC3, and PON1 as Potential Biomarkers for Yin-Deficiency-Heat Syndrome

Table 2

Downregulated serum proteins in YDH syndrome group quantified by iTRAQ-based proteomics and the ratios to the control group.

Protein IDGene nameProtein nameM/C (114/113)M/C (116/115)
Run 1Run 2MeanRun 1Run 2Mean

P02091HbbHemoglobin subunit beta-10.710.700.710.670.700.68
P05545Serpina3kSerine protease inhibitor A3K0.660.640.650.650.700.68
Q6IE52Mug2Murinoglobulin-20.670.750.710.420.730.58
P15978RT1-Aw2Class I histocompatibility antigen0.730.610.670.580.600.59
P36953AfmAfamin0.540.450.490.740.690.72
Q62894Ecm1Extracellular matrix protein 10.770.550.660.520.510.52
O88201Clec11aC-type lectin domain family 11 member A0.770.530.650.320.720.52
P55314C8bComplement component C8 beta chain0.740.740.740.370.470.42
P14630ApomApolipoprotein M0.640.440.540.530.600.57
P35859IgfalsInsulin-like growth facto0.500.580.540.440.580.51
P14046A1i3Alpha-1-inhibitor 30.480.560.520.670.340.50
Q64268Serpind1Heparin cofactor 20.740.700.720.240.310.27
Q68FP1GsnGelsolin0.560.580.570.310.520.41
Q00918Ltbp1Latent-transforming growth factor0.440.500.470.440.470.46
P23680ApcsSerum amyloid P-component0.730.690.710.220.210.22
Q8R2H5Gpld1Phosphatidylinositol0.530.690.610.300.310.31
P31211Serpina6Corticosteroid-binding globulin0.540.500.520.360.360.36
Q9QUH3Apoa5Apolipoprotein A-V0.530.530.530.390.280.33
P48199CrpC-reactive protein0.720.720.720.100.190.14
O70535LifrLeukemia inhibitory factor receptor0.330.400.360.460.520.49
P55797Apoc4Apolipoprotein C-IV0.330.530.430.430.410.42
P18292F2Prothrombin0.650.640.650.130.250.19
P07092Serpine2Glia-derived nexin0.520.370.440.420.140.28
P19939Apoc1Apolipoprotein C-I0.340.350.340.320.340.33
P07808NpyPro-neuropeptide Y0.630.290.460.130.240.19
O08770Gp5Platelet glycoprotein V0.370.560.460.170.140.15
P55159Pon1Serum paraoxonase/arylesterase 10.270.190.230.310.240.28
P06759Apoc3Apolipoprotein C-III0.410.280.350.130.110.12
P04638Apoa2Apolipoprotein A-II0.110.130.120.250.270.26

M, model group; C, control group. 114/113 and 116/115, two biological replicates; Run 1 and Run 2, two technical replicates.